In order to further evaluate the diagnostic values of TUSC8 and MYLIP in breast cancer, we used the receiver operating characteristic curve (ROC) analyses to assess the potential use of these two biomarkers for differentiation of breast cancer patients. This evidence concerns the gene MYLIP and breast cancer.